Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06821009 · ClinicalTrials.gov registry record · NA

Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening

A NA study of Colorectal Cancer Screening, sponsored by Digital Health Navigation Solutions.

Recruiting
Registry status
NA
Development phase
6,500
Enrollment target
2
Study locations

NCT06821009: Recruiting NA study of Colorectal Cancer Screening, sponsored by Digital Health Navigation Solutions.

NCT06821009 is a NA study of Colorectal Cancer Screening that is actively recruiting participants, run by Digital Health Navigation Solutions. The registered enrollment target is 6,500 participants, above the 5,541-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (17% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06821009, a NA study of Colorectal Cancer Screening, is actively recruiting participants, sponsored by Digital Health Navigation Solutions.

RECRUITING
Registry status
NA
Development phase
6,500 participants
Enrollment target
2
Study locations

Study Summary

mPATH-CRC (mobile Patient Technology for Health) is an automated direct-to-patient digital health program about colorectal cancer screening. The goal of this project is to test a cloud-based version of mPATH that patients can use at home independent of a scheduled medical visit. Patients will access mPATH on their own devices using a hyperlink sent via text message. The cloud version of mPATH will have the proven effective content of the tablet version, including the ability to request a screening test directly via the program. mPATH will then share this information with the patient's healthcare organization so screening can be arranged. This cloud-based version will be highly scalable, have broad reach, and be easy to support, making it a commercially viable product. This project will (1) test the reach and effectiveness of the mPATH web app in two different healthcare settings: a Fee-for-Service setting, and a value-based care setting; and (2) determine the value generated by mPATH in each healthcare setting.

Primary Outcome

The proportion of individuals who complete a CRC screening test (colonoscopy, FIT, or FIT-DNA) within 180 days of randomization in both arms

Interventions

  • OTHER mPATH-CRC
  • OTHER Usual Care (Control)

Study Locations (2)

Georgia

  • Atrium Health Floyd - Rome

North Carolina

  • Atrium Health Wake Forest Baptist - Winston-Salem

Trial Details

FieldValue
Enrollment Target 6,500 participants
Start Date 2025-06-09
Est. Completion 2026-06-30
Phase NA

What NCT06821009 shows while recruiting

NCT06821009 is an interventional study that assigns participants to a tested intervention. Its 6,500 participants enrollment target places it among the larger protocols in the corpus, above the 5,541-participant average among 19 other Colorectal Cancer Screening trials with a reported enrollment target (17% higher).

The record links to 1 condition, with Colorectal Cancer Screening appearing as the primary indexed condition, and to 2 interventions - of which mPATH-CRC is the first listed.

NCT06821009 reports a single indexed study location in Georgia, North Carolina.

Frequently Asked Questions

What is clinical trial NCT06821009 about?

NCT06821009 is a clinical study titled "Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening". mPATH-CRC (mobile Patient Technology for Health) is an automated direct-to-patient digital health program about colorectal cancer screening. The goal of this project is to test a cloud-based version of mPATH that patients can use at home independent of a scheduled medical visit. Patients will access...

What is the current status of trial NCT06821009?

This trial is currently recruiting. It is a NA study. The enrollment target is 6,500 participants. The study started on 2025-06-09. Estimated completion is 2026-06-30.

What conditions does trial NCT06821009 study?

This clinical trial studies the following conditions: Colorectal Cancer Screening.

What interventions are being tested in trial NCT06821009?

The interventions under investigation include: mPATH-CRC (OTHER), Usual Care (Control) (OTHER).

Who is sponsoring clinical trial NCT06821009?

This trial is sponsored by Digital Health Navigation Solutions, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06821009 being conducted?

This trial has 2 study locations across Georgia, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer Screening

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06821009's enrollment target sits among peer trials

6,500 3rd of 19 higher than 17 of 19 other Colorectal Cancer Screening trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Colorectal Cancer Screening trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00505245 · 6,500 participants

    New Assessment System in Measuring Symptom Distress in Cancer Patients

  • NCT05369429 · 6,516 participants · NA

    My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life

  • NCT05143697 · 6,600 participants · NA

    Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids

  • NCT05515224 · 6,600 participants · NA

    5-Cog 2.0: A Pragmatic Clinical Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06821009, the US trial registry maintained by the National Library of Medicine. NCT06821009 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.